NCT04821349

Brief Summary

Capsule Endoscopy (CE) is a safe, patient friendly and easy procedure performed for the evaluation of gastrointestinal tract unable to be explored via conventional endoscopy. The most common indication to perform SBCE is represented by Suspected Small Bowel Bleeding (SSBB). According to the widest meta-analysis available in literature, SBCE shows a diagnostic yield in SSBB of about 60%, and angiodysplasias are the most relevant findings, accounting for 50% of patients undergoing SBCE for SSBB. Accordingly, it represents the first line examination in SSBB investigation for determining the source of bleeding, if primary endoscopy results negative. Despite its high clinical feasibility, the evaluation of CE-video-captures is one of the main drawbacks since it is time consuming and requests the reader to concentrate to not miss any lesion. In order to reduce reading time, several software have been developed with the aim to cut similar images and select relevant images. For example, automated fast reading software have demonstrated to significantly reduce reading time without impacting the miss rate in pathological conditions affecting diffusely the mucosa (as IBD lesions do). Not the same assumption can be taken for isolated lesions since several studies reported an unacceptable miss rate for such a detection modality. New advancements such as artificial intelligence made their appearance in recent years. Deep convolutional neural networks (CNNs) have demonstrated to recognize specific images among a large variety up to exceed human performance in visual tasks. A Deep Learning model has been recently validated in the field of Small Bowel CE by Ding et al. According to their data collected on 5000 patients, the CNN-based auxiliary model identify abnormalities with 99.88% sensitivity in the per patient analysis and 99.90% sensitivity in the per-lesion analysis. With this perspective, it is believable that AI applied to SBCE can significantly shorten the reading time and support physicians to detect available lesions without losing significant lesions, further improving the diagnostic yield of the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

March 12, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 29, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

February 21, 2024

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

March 12, 2021

Last Update Submit

February 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy of AI-assisted video reading versus traditional video reading with conventional software.

    sensitivity, specificity, PPV, NPV calculated at per-patient analysis for P1 / P2 lesions, compared with the adjudication committee as gold standard in case of discrepancies.

    through study completion, an average of 1 year

Secondary Outcomes (6)

  • evaluation of Reading time of AI-assisted reading compared with conventional reading

    through study completion, an average of 1 year

  • Role of AI-assisted reading in real life from a health economic perspective

    through study completion, an average of 1 year

  • Accuracy of AI-assisted video reading versus traditional video reading with conventional software.

    through study completion, an average of 1 year

  • Accuracy of AI-assisted video reading versus traditional video reading with conventional software considering any lesions for a per-patient analysis with the adjudication committee as gold standard in case of discrepancies.

    through study completion, an average of 1 year

  • Diagnostic yield of CE

    through study completion, an average of 1 year

  • +1 more secondary outcomes

Study Arms (1)

Single arm study

OTHER

Standard reading Group vs AI-assisted reading Group

Device: Capsule endoscopy

Interventions

A consecutive series of patients recruited by 12 European centers based on the indication of OGIB will undergo capsule endoscopy examination. Capsule endoscopy will be performed in each site according to local rules and requirements, and the study protocol will concern only the post-procedure analysis on reading modalities for each patient.

Single arm study

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • indication of OGIB:1)after negative upper and lower endoscopy; 2)France: after negative pregnancy test; 3)Hb cut-off male: \<13, female: \<12

You may not qualify if:

  • Age \< 18 years old
  • Known or suspected intestinal obstruction
  • Non-steroidal anti-inflammatory drugs (twice weekly or more) during the 4 weeks preceding enrollment
  • Patient is expected to undergo MRI examination within 7 days after ingestion of the capsule
  • Patient with known gastrointestinal motility disorders
  • Subjects with known or suspected delayed gastric emptying
  • Patient suffers from any condition, such as swallowing problems, which precludes compliance with study and/or device instructions
  • Patient has any allergy or other known contraindication or intolerance to the medications used in the study
  • Patient has any condition, which precludes compliance with study and/or device instructions
  • Patient with any contraindication to take the bowel preparation product
  • Women who are either pregnant or nursing at the time of screening, or are of child- bearing potential and do not practice medically acceptable methods of contraception
  • Concurrent participation in another clinical trial using any investigational drug or device
  • Patient suffers from a life-threatening condition
  • Patients with history or clinical evidence of renal disease and/or previous clinically significant laboratory abnormalities of renal function parameters
  • Patients with pace-maker or implantable cardioverter
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Poliambulanza

Brescia, 25124, Italy

Location

Related Publications (1)

  • Spada C, Piccirelli S, Hassan C, Ferrari C, Toth E, Gonzalez-Suarez B, Keuchel M, McAlindon M, Finta A, Rosztoczy A, Dray X, Salvi D, Riccioni ME, Benamouzig R, Chattree A, Humphries A, Saurin JC, Despott EJ, Murino A, Johansson GW, Giordano A, Baltes P, Sidhu R, Szalai M, Helle K, Nemeth A, Nowak T, Lin R, Costamagna G. AI-assisted capsule endoscopy reading in suspected small bowel bleeding: a multicentre prospective study. Lancet Digit Health. 2024 May;6(5):e345-e353. doi: 10.1016/S2589-7500(24)00048-7.

MeSH Terms

Conditions

Anemia, Iron-Deficiency

Interventions

Capsule Endoscopy

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Each center will receive from another center anonymized patient videos that have been uploaded on an encrypted USB key. Indeed, expert gastroenterologists from each center will proceed with AI-assisted video reading without knowing which center the video comes from nor the results of the normal reading. Reading conditions are the same as for standard reading. Results from both normal and AI-assisted reading will be compared. In the case of significant disagreement between the results from conventional capsule endoscopy reading and AI-assisted reading (e.g. missed lesions), a consensus review for each center will be done. Any lesion shall be considered.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2021

First Posted

March 29, 2021

Study Start

February 16, 2021

Primary Completion

May 5, 2022

Study Completion

October 1, 2022

Last Updated

February 21, 2024

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

All data and source code can be made available after the manuscript publication on reasonable request, which must include an appropriate protocol, analysis plan, and data exchange with institutional approvals in place before data transfer of any information.

Shared Documents
STUDY PROTOCOL

Locations